000 | 01118 a2200277 4500 | ||
---|---|---|---|
005 | 20250512022512.0 | ||
264 | 0 | _c19890309 | |
008 | 198903s 0 0 eng d | ||
022 | _a0022-2828 | ||
024 | 7 |
_a10.1016/s0022-2828(88)80083-x _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aRhodes, D G | |
245 | 0 | 0 |
_aDiscussion of "Why do some drugs preferentially block open sodium channels?": consideration of other significant factors in the binding process. _h[electronic resource] |
260 |
_bJournal of molecular and cellular cardiology _cJun 1988 |
||
300 |
_a571-2 p. _bdigital |
||
500 | _aPublication Type: Editorial; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAnti-Arrhythmia Agents _xpharmacology |
650 | 0 | 4 |
_aCell Membrane _xphysiology |
650 | 0 | 4 |
_aHeart _xphysiology |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMyocardium _xcytology |
650 | 0 | 4 |
_aSodium Channels _xdrug effects |
700 | 1 | _aHerbette, L G | |
773 | 0 |
_tJournal of molecular and cellular cardiology _gvol. 20 _gno. 6 _gp. 571-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/s0022-2828(88)80083-x _zAvailable from publisher's website |
999 |
_c2856919 _d2856919 |